https://wiki.tradeville.ro/index.php?action=history&feed=atom&title=Harpoon_Therapeutics%2C_Inc.Harpoon Therapeutics, Inc. - Revizia istoricului2026-05-14T23:50:09ZIstoricul versiunilor pentru această pagină din wikiMediaWiki 1.39.2https://wiki.tradeville.ro/index.php?title=Harpoon_Therapeutics,_Inc.&diff=423099&oldid=prevAdmin: Pagină nouă: Pagina dedicata companiei Harpoon Therapeutics, Inc. listata cu simbolurile US.HARP, US.HARPc ==Descriere companie== Harpoon Therapeutics,(https://www.harpoontx.com/) Inc. is a clinical-stage immunotherapy company. The Company is engaged in the development of a novel class of T cell engagers that harness the power of the body’s immune system to treat patients suffering from cancer and other diseases. The Company is engaged in developing pipeline of novel T cell engagers us...2024-09-18T18:01:21Z<p>Pagină nouă: Pagina dedicata companiei Harpoon Therapeutics, Inc. listata cu simbolurile US.HARP, US.HARPc ==Descriere companie== Harpoon Therapeutics,(https://www.harpoontx.com/) Inc. is a clinical-stage immunotherapy company. The Company is engaged in the development of a novel class of T cell engagers that harness the power of the body’s immune system to treat patients suffering from cancer and other diseases. The Company is engaged in developing pipeline of novel T cell engagers us...</p>
<p><b>Pagină nouă</b></p><div>Pagina dedicata companiei Harpoon Therapeutics, Inc. listata cu simbolurile US.HARP, US.HARPc<br />
<br />
==Descriere companie==<br />
Harpoon Therapeutics,(https://www.harpoontx.com/) Inc. is a clinical-stage immunotherapy company. The Company is engaged in the development of a novel class of T cell engagers that harness the power of the body’s immune system to treat patients suffering from cancer and other diseases. The Company is engaged in developing pipeline of novel T cell engagers using TriTACs, focused on the treatment of solid tumors and hematologic malignancies. It has also nominated its clinical candidate using ProTriTAC platform, a prodrug version of TriTAC platform, designed to expand the target space for T cell engagers and bring the benefits of TriTACs to the patients. The Company’s four TriTAC product candidates include HPN424, HPN536, HPN217 and HPN328. The Company ProTriTAC product candidate include HPN601.<br />
<br />
==Grafic actiuni companie==<br />
<iframe key="tradeville" path="graficSimbol/US.HARP" /><br />
<iframe key="tradeville" path="graficSimbol/US.HARPc" /><br />
<br />
==Ultimele stiri despre Harpoon Therapeutics, Inc. (US.HARP)==<br />
<dynamicpagelist><br />
category=US.HARP<br />
count=10<br />
order=descending<br />
addfirstcategorydate=false<br />
</dynamicpagelist><br />
==Ultimele stiri despre Harpoon Therapeutics, Inc. (US.HARPc)==<br />
<dynamicpagelist><br />
category=US.HARPc<br />
count=10<br />
order=descending<br />
addfirstcategorydate=false<br />
</dynamicpagelist><br />
<br />
[[Categorie:US.HARP]][[Categorie:US.HARPc]][[Categorie:Stiri despre companii]]</div>Admin